Safety of anacetrapib in patients with or at high risk for coronary heart disease

Authors :: Cannon, Christopher P.
Shah, Sukrut
Dansky, Hayes M.
Davidson, Michael
Brinton, Eliot A.
Gotto, Antonio M. Jr.
Stepanavage, Michael
Liu, Sherry Xueyu
Gibbons, Patrice
Ashraf, Tanya B.
Zafarino, Jennifer
Mitchel, Yale
Barter, Philip
Source :: The New England Journal of Medicine. Dec 16, 2010, Vol. 363 Issue 25, p2406, 10 p.
Publication Year :: 2010
Abstract: A study was conducted to evaluate the efficacy and safety of anacetrapib in patients with or at high risk for coronary heart disease. Results indicated that anacetrapib treatment was found to be quite safe as well as effective on LDL and HDL cholesterol.

Subjects :: Anacetrapib -- Usage
Anacetrapib -- Health aspects
Cholesterol -- Health aspects
Coronary heart disease -- Drug therapy

Tools